*The information presented in this article is provided solely for scientific, educational, and laboratory reference purposes
Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study
While this synthesis summarises PET-specific evidence, several frequently reported biological pathways (e.g., oxidative stress and inflammation) are not unique to PET and may be driven primarily by particle size, surface properties, dose metrics, and exposure duration rather than polymer identity alone
semaglutide (0.05, 0.1, 0.2, 0.3 mg), or liraglutide (0.3, 0.6, 1.2, 1.8 mg) or placebo (50, 100, 200, 300 L)